Form 4: NHC Senior VP Exercises Stock Options, Adjusts Holdings
Insider Transaction Report
National Healthcare Corp's Senior VP & General Counsel, Josh A. McCreary, exercised 4,000 stock options and adjusted common stock holdings.
Summary
- Josh A. McCreary, Senior VP & General Counsel of National Healthcare Corp (NHC), exercised 4,000 stock options on November 11, 2025.
- These options were granted on March 5, 2024, under the 2020 Omnibus Equity Incentive Plan, with an exercise price of $94.1 per share.
- Following the exercise, 3,278 shares were withheld by the company at a price of $132.2 per share to cover the exercise price and tax obligations.
- After these transactions, McCreary beneficially owns 10,438 shares of NHC common stock directly.
- McCreary still holds 8,000 unexercised options from the March 5, 2024 grant, which expire on March 5, 2029.
- Additionally, McCreary holds other unexercised options: 4,000 shares with an exercise price of $53.94 (expiring March 8, 2028) and 13,500 shares with an exercise price of $90.62 (expiring February 24, 2030).
Sentiment
Score: 7
Explanation: The exercise of stock options by a senior executive generally indicates confidence in the company's future prospects, even with shares being withheld for taxes. The options were significantly in-the-money.
Positives
- An insider, Josh A. McCreary, exercised stock options, indicating confidence in the company's value.
- The exercise price of $94.1 is significantly lower than the $132.2 price at which shares were withheld for taxes, suggesting a substantial in-the-money value for the options.
Negatives
- A significant portion (3,278 out of 4,000 acquired shares) was disposed of to cover exercise costs and taxes, which, while common, reduces the net increase in direct ownership.
Future Outlook
N/A
Industry Context
N/A
Stakeholder Impact
- Shareholders: The transaction shows an insider increasing their net direct ownership, which can be seen as a positive signal of management's belief in the company's value.
Key Dates
| Date | Description |
|---|---|
| 2024-03-05 | Grant date of 4,000 stock options with an exercise price of $94.1 under the 2020 Omnibus Equity Incentive Plan. |
| 2024-03-08 | Date 4,000 stock options with an exercise price of $53.94 became exercisable. |
| 2025-03-05 | Date 12,000 stock options with an exercise price of $94.1 became exercisable. |
| 2025-11-11 | Date of stock option exercise and common stock transactions by Josh A. McCreary. |
| 2025-11-13 | Date the Form 4 was signed by Josh A. McCreary. |
| 2026-02-24 | Date 13,500 stock options with an exercise price of $90.62 became exercisable. |
| 2028-03-08 | Expiration date of 4,000 stock options with an exercise price of $53.94. |
| 2029-03-05 | Expiration date of 12,000 stock options with an exercise price of $94.1. |
| 2030-02-24 | Expiration date of 13,500 stock options with an exercise price of $90.62. |
Recommendation
holdThe exercise of stock options by a Senior VP and General Counsel, resulting in a net increase in direct beneficial ownership, is a positive signal of management confidence. However, this single transaction alone does not provide sufficient information to alter a broader investment thesis, thus a 'hold' recommendation is appropriate, pending further fundamental analysis.
Keywords
National Healthcare Corp, NHC, Form 4, Insider Trading, Stock Options, Executive Compensation, Josh McCreary, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.